Alkermes Medicines & Focus: Serious Mental Illness

We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder.

Videos from this campaign

Alkermes Pathways

Content from this campaign

Diversity & Inclusion

Alkermes Celebrates National Minority Health Month
This National Minority Health Month, we’re learning more about the disproportionate prevalence of mental illness, socioeconomic disparities & barriers to care in minority communities.

Health & Healthcare

Alkermes + Mental Health Missions
This April, we're talking about Mental Health Missions and making mental health a priority.

Health & Healthcare

Alkermes Commits to Being #BipolarBrave on World Bipolar Day
Today we observe World Bipolar Day to help lift the ~2.8% of American adults living with #bipolar disorder & coping with extreme highs & lows in mood & energy.

Media & Communications

Alkermes & MD Edge Psych Podcast Discuss Living With Schizophrenia
Dr. Rakesh Jain and Dr. Andrew Cutler guest hosted the Alkermes-sponsored MDEdge Psychiatry podcast to discuss the management of comorbidities & behavioral risk factors that may be present in people living with schizophrenia.

Health & Healthcare

Alkermes Provides Tips on Talking to a Doctor About Your Mental Health
Early identification of a serious mental illness and intervention can be critical to disease management and improved long-term outcomes for individuals.

Health & Healthcare

Alkermes Celebrates Brain Awareness Week
It's Brain Awareness Week! Raising awareness & advocating for research funding is crucial to improving the lives of people with schizophrenia & bipolar disorder.

Responsible Business & Employee Engagement

Alkermes VP of Marketing Shares What Inspires His Work
We continue to recognize our passionate employees by spotlighting their “Why” for joining the Alkermes psychiatry team. Damon Harrell, VP of Marketing, shares why he’s inspired to make a difference for those living with serious mental illness.

Responsible Business & Employee Engagement

Alkermes Employee Shares How Her Experience With Bipolar Disorder Inspires Her at Work
Meet Jessica Tamborski -- an Alkermes employee inspired by her daughter’s struggle with bipolar disorder who is proud to work at an organization that helps people living with serious mental illness.

Health & Healthcare

Alkermes Provides Information and Resources About Telepsych
Psychiatrist Dr. Frank Chen sat down with PsychCentral.com’s Gabe Howard to discuss the benefits of telepsych and why it doesn’t need to be so intimidating.

Health & Healthcare

How Does Schizophrenia Affect the Brain?
Schizophrenia is a serious brain disorder affecting about 2.4 million adults in the United States. But exactly how does this disease affect certain parts of the brain?
Alkermes logo

More from Alkermes

  1. Alkermes: Corporate Responsibility
    We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

  2. Alkermes: Diversity, Inclusion & Belonging
    Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

  3. Alkermes Medicines & Focus: Serious Mental Illness
    We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

  4. Alkermes Medicines & Focus: Cancer
    We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

  5. Alkermes Inspiration Grants®
    Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

  6. Alkermes Medicines & Focus: Addiction
    We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...